156P A phase Ib/II study of nanatinostat (Nstat) plus valganciclovir (VGCV) in advanced Epstein-Barr virus positive (EBV+) solid tumors and with pembrolizumab (PEM) in recurrent/metastatic nasopharyngeal carcinoma (RM-NPC). (December 2022) - Colevas, A.D.; Siu, L.L.; Lim, D.W-T.; Gao, B.; Khan, S.A.; Eng, L.; Voon, P.J.; Ahn, M-J.; Elguindy, A.; Katkov, A.; Rojkjaer, L.; Katz, Y.; et al.